Home > Publications database > A Multidisciplinary Approach to Impact Acute Care Utilization in Sickle Cell Disease. > print

001     132851
005     20240229105035.0
024 7 _ |a 10.1177/1062860617707262
|2 doi
024 7 _ |a pmid:28460533
|2 pmid
024 7 _ |a 1062-8606
|2 ISSN
024 7 _ |a 1555-824X
|2 ISSN
024 7 _ |a altmetric:20938118
|2 altmetric
037 _ _ |a DKFZ-2018-00494
041 _ _ |a eng
082 _ _ |a 610
100 1 _ |a Powell, Rhea E
|b 0
245 _ _ |a A Multidisciplinary Approach to Impact Acute Care Utilization in Sickle Cell Disease.
260 _ _ |a Thousand Oaks, Calif. [u.a.]
|c 2018
|b Sage Publ.
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1525867704_22379
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Sickle cell disease (SCD), an inherited red blood cell disorder, is characterized by anemia, end-organ damage, unpredictable episodes of pain, and early mortality. Emergency department (ED) visits and hospitalizations are frequent, leading to increased burden on patients and increased health care costs. This study assessed the effects of a multidisciplinary care team intervention on acute care utilization among adults with SCD. The multidisciplinary care team intervention included monthly team meetings and development of individualized care plans. Individualized care plans included targeted pain management plans for management of uncomplicated pain crisis. Following implementation of the multidisciplinary care team intervention, a significant decrease in ED utilization was identified among those individuals with a history of high ED utilization. Findings highlight the potential strength of multidisciplinary interventions and suggest that targeting interventions toward high-utilizing subpopulations may offer the greatest impact.
536 _ _ |a 313 - Cancer risk factors and prevention (POF3-313)
|0 G:(DE-HGF)POF3-313
|c POF3-313
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
700 1 _ |a Lovett, Paris B
|b 1
700 1 _ |a Crawford, Albert
|b 2
700 1 _ |a McAna, John
|b 3
700 1 _ |a Axelrod, David
|b 4
700 1 _ |a Ward, Lawrence
|b 5
700 1 _ |a Pulte, Dianne
|0 P:(DE-He78)3772dc9cbbc020fbc52b5f63f1dc1e96
|b 6
|e Last author
|u dkfz
773 _ _ |a 10.1177/1062860617707262
|g Vol. 33, no. 2, p. 127 - 131
|0 PERI:(DE-600)2181248-2
|n 2
|p 127 - 131
|t American journal of medical quality
|v 33
|y 2018
|x 1555-824X
909 C O |o oai:inrepo02.dkfz.de:132851
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 6
|6 P:(DE-He78)3772dc9cbbc020fbc52b5f63f1dc1e96
913 1 _ |a DE-HGF
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-313
|2 G:(DE-HGF)POF3-300
|v Cancer risk factors and prevention
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
|b Gesundheit
914 1 _ |y 2018
915 _ _ |a Allianz-Lizenz / DFG
|0 StatID:(DE-HGF)0400
|2 StatID
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b AM J MED QUAL : 2015
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
920 1 _ |0 I:(DE-He78)C070-20160331
|k C070
|l Klinische Epidemiologie und Alternsforschung
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C070-20160331
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21